ADMA Biologics Inc- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 ADMA Biologics Inc 公司

ADMA Biologics, Inc. 是一家端到端商业生物制药公司，致力于制造、营销和开发用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者的特种生物制剂。该公司制造和营销三种经美国食品药品管理局 (FDA) 批准的血浆衍生生物制剂，用于治疗免疫缺陷和预防某些传染病：BIVIGAM（人静脉注射免疫球蛋白），用于治疗原发性体液免疫缺陷 (PI)；ASCENIV（人静脉注射免疫球蛋白 - slra 10% 液体），用于治疗 PI；NABI-HB（人乙肝免疫球蛋白），用于增强对乙肝病毒的免疫力。通过其子公司 ADMA BioCenters，该公司还在美国经营 FDA 批准的血浆采集者，为其产品制造提供血浆。

公司简介

公司代码ADMA

公司名称ADMA Biologics Inc

上市日期Oct 17, 2013

CEOMr. Adam S. Grossman

员工数量677

证券类型Ordinary Share

年结日Oct 17

公司地址465 State Route 17

城市RAMSEY

上市交易所NASDAQ Global Market Consolidated

国家United States of America

邮编07446

电话12014785552

网址https://www.admabiologics.com/

公司代码ADMA

上市日期Oct 17, 2013

CEOMr. Adam S. Grossman

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. Adam S. Grossman

President, Chief Executive Officer, Co-Founder, Director

3.75M

-0.16%

Dr. Jerrold B. Grossman

Vice Chairman of the Board, Co-Founder

570.90K

--

Mr. Brad L. Tade

Chief Financial Officer, Treasurer

258.17K

-2.68%

Mr. Lawrence P. Guiheen

Independent Director

145.83K

-12.06%

Mr. Steven A. (Steve) Elms

Independent Chairman of the Board

87.33K

--

Mr. Eduardo Rene Salas

Independent Director

10.89K

--

Dr. Young T. Kwon, Ph.D.

Independent Director

--

Ms. Alison C. Finger

Independent Director

--

Ms. Kaitlin Kestenberg

Chief Operating Officer, Senior Vice President - Compliance

--

名称

名称/职务

职务

持股

持股变动

Mr. Adam S. Grossman

President, Chief Executive Officer, Co-Founder, Director

3.75M

-0.16%

Dr. Jerrold B. Grossman

Vice Chairman of the Board, Co-Founder

570.90K

--

Mr. Brad L. Tade

Chief Financial Officer, Treasurer

258.17K

-2.68%

Mr. Lawrence P. Guiheen

Independent Director

145.83K

-12.06%

Mr. Steven A. (Steve) Elms

Independent Chairman of the Board

87.33K

--

Mr. Eduardo Rene Salas

Independent Director

10.89K

--

收入明细

单位: USD更新时间: 7月6日周日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

暂无数据

地区USD

名称

营收

占比

United States

110.73M

96.45%

International

4.07M

3.55%

业务

地区

暂无数据

股东统计

更新时间: 8月27日周三

持股股东

股东类型

持股股东

占比

BlackRock Institutional Trust Company, N.A.

13.98%

The Vanguard Group, Inc.

8.93%

State Street Global Advisors (US)

5.06%

Invesco Advisers, Inc.

4.27%

Geode Capital Management, L.L.C.

2.48%

其他

65.28%

持股股东

占比

BlackRock Institutional Trust Company, N.A.

13.98%

The Vanguard Group, Inc.

8.93%

State Street Global Advisors (US)

5.06%

Invesco Advisers, Inc.

4.27%

Geode Capital Management, L.L.C.

2.48%

其他

65.28%

股东类型

持股股东

占比

Investment Advisor

49.43%

Investment Advisor/Hedge Fund

30.02%

Hedge Fund

5.67%

Individual Investor

2.56%

Research Firm

2.00%

Private Equity

1.44%

Pension Fund

1.26%

Bank and Trust

0.44%

Venture Capital

0.24%

其他

6.96%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

680

225.21M

94.37%

-6.16M

2025Q1

658

218.51M

91.53%

-12.93M

2024Q4

607

216.39M

91.46%

-18.31M

2024Q3

547

221.08M

93.58%

+11.33M

2024Q2

451

193.54M

83.08%

-7.68M

2024Q1

408

187.57M

81.05%

-5.26M

2023Q4

371

181.77M

80.46%

-8.48M

2023Q3

362

185.07M

81.97%

+86.17K

2023Q2

349

179.85M

80.15%

-7.63M

2023Q1

335

188.11M

85.60%

+12.05M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

34.20M

14.32%

-829.83K

-2.37%

Mar 31, 2025

The Vanguard Group, Inc.

16.79M

7.03%

-1.36M

-7.48%

Mar 31, 2025

State Street Global Advisors (US)

11.44M

4.79%

-3.43M

-23.07%

Mar 31, 2025

Invesco Advisers, Inc.

9.69M

4.06%

+483.20K

+5.25%

Mar 31, 2025

Geode Capital Management, L.L.C.

5.67M

2.37%

+235.43K

+4.33%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

4.86M

2.04%

+191.99K

+4.11%

Mar 31, 2025

American Century Investment Management, Inc.

4.25M

1.78%

+478.80K

+12.69%

Mar 31, 2025

Nuveen LLC

3.46M

1.45%

+234.51K

+7.27%

Mar 31, 2025

Grossman (Adam S)

3.77M

1.58%

-6.00K

-0.16%

Jun 16, 2025

Allspring Global Investments, LLC

3.05M

1.28%

+207.10K

+7.29%

Mar 31, 2025

持股ETF

更新时间: 9月6日周六

机构名称

占比

Invesco S&P SmallCap Quality ETF

1.2%

Pacer US Small Cap Cash Cows Growth Leaders ETF

1.03%

Harbor Health Care ETF

0.94%

Janus Henderson Small Cap Growth Alpha ETF

0.78%

First Trust NASDAQ Pharmaceuticals ETF

0.59%

OneAscent Small Cap Core ETF

0.52%

Fidelity Momentum Factor ETF

0.52%

ProShares Ultra Nasdaq Biotechnology

0.48%

Invesco Nasdaq Biotechnology ETF

0.45%

Vident US Equity Strategy ETF

0.42%

Invesco S&P SmallCap Quality ETF

占比1.2%

Pacer US Small Cap Cash Cows Growth Leaders ETF

占比1.03%

Harbor Health Care ETF

占比0.94%

Janus Henderson Small Cap Growth Alpha ETF

占比0.78%

First Trust NASDAQ Pharmaceuticals ETF

占比0.59%

OneAscent Small Cap Core ETF

占比0.52%

Fidelity Momentum Factor ETF

占比0.52%

ProShares Ultra Nasdaq Biotechnology

占比0.48%

Invesco Nasdaq Biotechnology ETF

占比0.45%

Vident US Equity Strategy ETF

占比0.42%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

ADMA Biologics Inc

15.910USD

ADMA Biologics Inc

15.910

概览

公司

财务

分析